Virus-host interactions in HIV pathogenesis: directions for therapy.
1Director, Laboratory for Tumor and AIDS Virus Research, University of California, San Francisco, San Francisco, CA 94143-1270, USA. Jay.Levy@ucsf.edu
Advances in Dental Research
|March 29, 2011
Summary
Understanding HIV heterogeneity, transmission, and host factors is key to controlling infection. Focusing on the innate immune response offers the best chance for developing effective HIV therapies and an AIDS vaccine.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Human Immunodeficiency Virus (HIV) presents a complex challenge due to its genetic diversity and broad cellular tropism.
- Understanding natural resistance mechanisms in long-term non-progressors is crucial for developing effective interventions.
- HIV transmission routes and host-intrinsic factors significantly influence infection control.
Purpose of the Study:
- To explore the multifaceted challenges in controlling HIV infection.
- To investigate natural mechanisms of resistance to HIV infection and disease progression.
- To highlight the importance of the innate immune response in early HIV control.
Main Methods:
- Review of existing literature on HIV pathogenesis, transmission, and host-cell interactions.
- Analysis of immunological and cellular factors involved in HIV resistance.
- Identification of key parameters for developing anti-HIV therapies and vaccines.
Main Results:
- HIV's heterogeneity and wide host range complicate control efforts.
- Long-term non-progressors offer insights into natural resistance mechanisms.
- The innate immune response is a critical window for early HIV intervention.
Conclusions:
- A comprehensive understanding of HIV pathogenesis is essential for therapeutic and vaccine development.
- Targeting the innate immune system may provide optimal strategies for controlling HIV.
- Further research into natural resistance is vital for advancing HIV/AIDS prevention and treatment.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...


